SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
D2 and D3 dopamine receptor affinity predicts effectiveness of antipsychotic drugs in obsessive-compulsive disorders: a metaregression analysis
16 references·2 citing·38 second hop
D2 and D3 dopamine receptor affinity predicts effectiveness of antipsychotic drugs in obsessive-compulsive disorders: a metaregression analysis (2014)D2 and D3 dopamine receptor affinity pred…Introduction to Meta‐Analysis (2021)Introduction to Meta‐AnalysisGrand Challenges in Global Mental Health: Integration in Research, Policy, and Practice (2013)Grand Challenges in Global Me…Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder (2013)Dopaminergic activity in Tour…Evidence-based pharmacotherapy of obsessive-compulsive disorder (2012)Evidence-based pharmacotherap…Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials (2012)Antipsychotic augmentation of…Introduction to Meta‐Analysis (2009)Introduction to Meta‐AnalysisIn vivo PET study of 5HT2A serotonin and D2 dopamine dysfunction in drug-naive obsessive-compulsive disorder (2008)In vivo PET study of 5HT2A se…Prevalence and Incidence Studies of Anxiety Disorders: A Systematic Review of the Literature (2006)Prevalence and Incidence Stud…A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder (2006)A systematic review: antipsyc…Evidence-based pharmacotherapy of obsessive–compulsive disorder (2005)Evidence-based pharmacotherap…The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence. (2004)The role of dopamine in obses…Augmentation of Serotonin Reuptake Inhibitors in Refractory Obsessive-Compulsive Disorder Using Adjunctive Olanzapine (2004)Augmentation of Serotonin Reu…A Double-Blind, Randomized, Placebo-Controlled Trial of Quetiapine Addition in Patients With Obsessive-Compulsive Disorder Refractory to Serotonin Reuptake Inhibitors (2004)A Double-Blind, Randomized, P…A Double-blind, Placebo-Controlled Study of Risperidone Addition in Serotonin Reuptake Inhibitor–Refractory Obsessive-compulsive Disorder (2000)A Double-blind, Placebo-Contr…Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder (1999)Family-based association stud…Haloperidol Addition in Fluvoxamine-Refractory Obsessive-Compulsive Disorder (1994)Haloperidol Addition in Fluvo…Pharmacotherapeutic Strategies and New Targets in OCD (2021)Pharmacotherapeutic Strategie…Obsessive–compulsive disorder (2019)Obsessive–compulsive disorderNeuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder (1998)Quinpirole induces compulsive checking behavior in rats: A potential animal model of obsessive-compulsive disorder (OCD). (1998)'Behavioral' Addictions: Do They Exist? (2001)Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: The orbitofronto-striatal model revisited (2007)Probing Compulsive and Impulsive Behaviors, from Animal Models to Endophenotypes: A Narrative Review (2009)Deep Brain Stimulation of the Nucleus Accumbens for Treatment-Refractory Obsessive-Compulsive Disorder (2010)The Yale Global Tic Severity Scale: Initial Testing of a Clinician-Rated Scale of Tic Severity (1989)The Yale-Brown Obsessive Compulsive Scale (1989)Anxiety disorders in women (2003)The genetics of obsessive-compulsive disorder: a review (2010)Molecular genetics of obsessive–compulsive disorder: a comprehensive meta-analysis of genetic association studies (2012)Diagnostic and Statistical Manual of Mental Disorders (2013)THE ASSESSMENT OF ANXIETY STATES BY RATING (1959)The Yale-Brown Obsessive Compulsive Scale (1989)Toward a Neurobiology of Obsessive-Compulsive Disorder (2000)Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2008)Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders (2014)Lifetime and 12-Month Prevalence of DSM-III-R Psychiatric Disorders in the United States (1994)Bias in meta-analysis detected by a simple, graphical test (1997)The Cochrane Library (2005)Obsessive-compulsive disorder (2009)A RATING SCALE FOR DEPRESSION (1960)The neuropsychology of obsessive compulsive disorder: the importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers (2005)Cochrane Database of Systematic Reviews (2008)Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology (2014)Posttraumatic Stress Disorder in the National Comorbidity Survey (1995)Long-term mental health of war-refugees: a systematic literature review (2015)A systematic review of reviews on the prevalence of anxiety disorders in adult populations (2016)ECDEU Assessment Manual for Psychopharmacology (1976)World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision (2008)The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication (2008)Diagnostic and Statistical Manual of Mental Disorders (2013)Exacerbation of obsessive compulsive disorder symptoms in children and adolescents during COVID-19 pandemic (2020)Psychological, addictive, and health behavior implications of the COVID-19 pandemic (2020)Toward a neurocircuit-based taxonomy to guide treatment of obsessive–compulsive disorder (2021)A basic introduction to fixed-effect and random-effects models for meta-analysis (2010)Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs (2013)How to perform a meta-analysis with R: a practical tutorial (2019)
this work references cited by second hop

References

  • 2009Introduction to Meta‐Analysis14,348 cited
  • 2021Introduction to Meta‐Analysis9,845 cited
  • 2006Prevalence and Incidence Studies of Anxiety Disorders: A Systematic Review of the Literature1,113 cited
  • 2006A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder637 cited
  • 2000A Double-blind, Placebo-Controlled Study of Risperidone Addition in Serotonin Reuptake Inhibitor–Refractory Obsessive-compulsive Disorder571 cited
  • 1994Haloperidol Addition in Fluvoxamine-Refractory Obsessive-Compulsive Disorder570 cited
  • 2012Evidence-based pharmacotherapy of obsessive-compulsive disorder336 cited
  • 2004The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence.279 cited
  • 1999Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder263 cited
  • 2004A Double-Blind, Randomized, Placebo-Controlled Trial of Quetiapine Addition in Patients With Obsessive-Compulsive Disorder Refractory to Serotonin Reuptake Inhibitors248 cited
  • 2013Grand Challenges in Global Mental Health: Integration in Research, Policy, and Practice220 cited
  • 2004Augmentation of Serotonin Reuptake Inhibitors in Refractory Obsessive-Compulsive Disorder Using Adjunctive Olanzapine220 cited
  • 2008In vivo PET study of 5HT2A serotonin and D2 dopamine dysfunction in drug-naive obsessive-compulsive disorder

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

219 cited
  • 2005Evidence-based pharmacotherapy of obsessive–compulsive disorder213 cited
  • 2012Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials211 cited
  • 2013Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder170 cited
  • Cited by

    • 2019Obsessive–compulsive disorder986 cited
    • 2021Pharmacotherapeutic Strategies and New Targets in OCD51 cited